Coloplast A/S (XSWX:COLOB)
CHF 115 0 (0%) Market Cap: 22.64 Bil Enterprise Value: 25.50 Bil PE Ratio: 39.65 PB Ratio: 11.19 GF Score: 91/100

Q3 2020 Coloplast A/S Earnings Call Transcript

Aug 18, 2020 / 01:00PM GMT
Release Date Price: CHF111
Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Good afternoon, and welcome to our third quarter '19/'20 conference call. I'm Kristian Villumsen, CEO of Coloplast, and I'm joined by CFO, Anders Lonning-Skovgaard and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions.

I'd like to start by thanking all of our employees at Coloplast, who serve users and our clinician partners every day during these challenging times of a global pandemic. As a company, our priorities during COVID have remained clear to keep our people safe, continue to serve our customers and maintain business operations. We've done this throughout the COVID-19 pandemic, and I'm very pleased with that.

Please turn to Slide #3. Before I dive into today's results, I'd like to zoom out and talk about the next 5 years for a minute. We're currently in the process of finalizing our 2025 strategy, which will be launched at our Capital Markets Day at the end of September. And at the core of the new strategy are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot